Clinical trialNCT06979323RecruitingPhase 3Interventional

Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

SponsorGlaxoSmithKlineEnrollment150Asthma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and worsen unpredictably.\\xa0The purpose of this study is to assess how depemokimab, a monoclonal antibody, affects the structure and function of the lungs in asthmatic participants with type 2 inflammation, characterized by an eosinophilic phenotype.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

GSK Clinical Trials
GlaxoSmithKline
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

50 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium

Gsk Investigational Site
Mechelen, Belgium
Muriel Lins
Recruiting
Gsk Investigational Site
Namur, Belgium
Jean-Benoît MARTINOT
Recruiting

Canada

Gsk Investigational Site
Ajax, Ontario, Canada
George Philteos
Recruiting
Gsk Investigational Site
Hamilton, Ontario, Canada
Imran Satia
Recruiting
Gsk Investigational Site
London, Ontario, Canada
Hana Serajeddini
Recruiting

China

Gsk Investigational Site
Guangzhou, China
Ruchong Chen
Recruiting
Gsk Investigational Site
Shanghai, China
Min Zhang
Recruiting
Gsk Investigational Site
Tianjin, China
Jie Cao
Recruiting

France

Gsk Investigational Site
Brest, France
Raphael Le Mao
Recruiting
Gsk Investigational Site
Créteil, France
Amel Boudjemaa
Recruiting
Gsk Investigational Site
La Tronche, France
Bruno Degano
Recruiting
Gsk Investigational Site
Pessac, France
Patrick Berger
Recruiting
Gsk Investigational Site
Reims, France
Jeanne-Marie Perotin-Collard
Recruiting

Germany

Gsk Investigational Site
Bonn, Germany
Dirk Skowasch
Recruiting
Gsk Investigational Site
Frankfurt, Germany
Claus Keller
Recruiting

Greece

Gsk Investigational Site
Athens, Greece
Paraskevi Katsaounou
Recruiting
Gsk Investigational Site
Athens, Greece
Nikolaos Zias
Recruiting
Gsk Investigational Site
Heraklion, Greece
KATERINA ANTONIOU
Recruiting
Gsk Investigational Site
Ioannina, Greece
Konstantinos Kostikas
Recruiting
Gsk Investigational Site
Thessaloniki, Greece
Konstantinos Porpodis
Recruiting

Italy

Gsk Investigational Site
Catania, Italy
Carlo Vancheri
Recruiting
Gsk Investigational Site
Genova, Italy
Diego Bagnasco
Recruiting
Gsk Investigational Site
Roma, Italy
Cristiano Caruso
Recruiting
Gsk Investigational Site
Rozzano, Italy
Enrico Marco Heffler
Recruiting

South Korea

Gsk Investigational Site
Jeonju, South Korea
So Ri Kim
Recruiting
Gsk Investigational Site
Seoul, South Korea
Heung-Woo Park
Recruiting
Gsk Investigational Site
Seoul, South Korea
Byung Jae Lee
Recruiting
Gsk Investigational Site
Seoul, South Korea
Jung-Won Park
Recruiting

Spain

Gsk Investigational Site
Barcelona, Spain
Ebymar Arismendi Nunez
Recruiting
Gsk Investigational Site
Barcelona, Spain
Mariana Muñoz Esquerre
Recruiting
Gsk Investigational Site
Benalmádena, Spain
Gustavo de Luiz Martínez
Recruiting
Gsk Investigational Site
Madrid, Spain
Ismael Ali Garcia
Recruiting
Gsk Investigational Site
Palma de Mallorca, Spain
Francisco de Borja García-Cosio Piqueras
Recruiting
Gsk Investigational Site
Santander, Spain
Juan Luis Garcia
Recruiting

Taiwan

Gsk Investigational Site
Kaohsiung City, Taiwan
Chau-Chyun Sheu
Recruiting
Gsk Investigational Site
Taichung, Taiwan
Ming-Cheng Chan
Recruiting
Gsk Investigational Site
Taipei, Taiwan
Pai-Chien Chou
Recruiting

United Kingdom

Gsk Investigational Site
Bradford, United Kingdom
Dinesh Saralaya
Recruiting
Gsk Investigational Site
London, United Kingdom
David Jackson
Recruiting
Gsk Investigational Site
London, United Kingdom
Salman Siddiqui
Recruiting

10 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Depemokimab

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 Jul 2024
Primary completion: 5 Jan 2028
Completion: 11 Feb 2028
Last update posted: 2 Jul 2026
Registered enrollment: 150
Registry id: NCT06979323

Cross-registrations

EU-CTR / CTIS (EudraCT)2024-519976-19

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.